BBS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.684800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.681400E-01
Normal-vs-Stage2
5.321000E-01
Normal-vs-Stage3
7.992300E-02
Normal-vs-Stage4
7.391400E-01
Stage1-vs-Stage2
1.260950E-01
Stage1-vs-Stage3
1.375070E-03
Stage1-vs-Stage4
8.990600E-01
Stage2-vs-Stage3
4.464100E-02
Stage2-vs-Stage4
2.427600E-01
Stage3-vs-Stage4
5.409700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.534200E-01
Normal-vs-AfricanAmerican
9.237000E-01
Normal-vs-Asian
6.414600E-01
Caucasian-vs-AfricanAmerican
6.493600E-01
Caucasian-vs-Asian
7.763400E-01
AfricanAmerican-vs-Asian
6.253600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.767000E-01
Normal-vs-Female
7.635400E-01
Male-vs-Female
5.399600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.493800E-01
Normal-vs-Age(41-60Yrs)
9.911600E-01
Normal-vs-Age(61-80Yrs)
5.901400E-01
Normal-vs-Age(81-100Yrs)
1.954570E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.108000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.354400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.233780E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.925600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.721540E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.887220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.588000E-01
Normal-vs-Daily Drinker
4.723200E-01
Normal-vs-Weekly Drinker
5.238200E-01
Normal-vs-Occasional Drinker
8.677800E-01
Normal-vs-Social Drinker
8.834400E-01
Non Drinker-vs-Daily Drinker
5.162200E-01
Non Drinker-vs-Weekly Drinker
7.216400E-01
Non Drinker-vs-Occasional Drinker
8.616000E-02
Non Drinker-vs-Social Drinker
1.936060E-02
Daily Drinker-vs-Weekly Drinker
8.849000E-01
Daily Drinker-vs-Occasional Drinker
1.876200E-01
Daily Drinker-vs-Social Drinker
1.129610E-01
Weekly Drinker-vs-Occasional Drinker
2.253000E-01
Weekly Drinker-vs-Social Drinker
1.637750E-01
Occasional Drinker-vs-Social Drinker
8.798200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.095700E-02
Normal-vs-Grade 2
7.956100E-04
Normal-vs-Grade 3
5.956700E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.078400E-01
Grade 1-vs-Grade 3
9.430400E-01
Grade 1-vs-Grade 4
8.095700E-02
Grade 2-vs-Grade 3
3.387800E-01
Grade 2-vs-Grade 4
7.956100E-04
Grade 3-vs-Grade 4
5.956700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.623800E-01
Normal-vs-NonDiabetic
7.756000E-01
Diabetic-vs-NonDiabetic
2.583800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.143400E-01
Normal-vs-NoPancreatitis
6.505600E-01
Pancreatitis-vs-NoPancreatitis
6.676000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.544400E-01
Normal-vs-N1
5.525600E-01
N0-vs-N1
4.162400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.029800E-01
Normal-vs-TP53-NonMutant
9.081200E-01
TP53-Mutant-vs-TP53-NonMutant
4.257000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
